Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site

Summary

investigate the molecular differences between primitive lung cancer and the metastatic site.

Eligibility

Inclusion Criteria:

* patients aged ≥18 years fit enough to tolerate the surgical operation;
* the operative risk is considered low based on respiratory reserve and cardiac assessment;
* the patient has clearly expressed willingness to adhere;
* availability of pathological material for tumor DNA extraction and NGS execution.

Exclusion Criteria:

* Women of childbearing age, pregnant or breastfeeding, or intending to become pregnant during the study.
* Any other illness, metabolic disorder, physical examination, or laboratory findings that constitute a contraindication to study participation.
* Recent or ongoing severe or clinically significant infection.

Conditions4

Browse More Trials